openPR Logo
Press release

North America Is Projected To Hold a Dominant Position in the Global Peptide Synthesis Market In The Near Future

07-27-2021 06:27 PM CET | Health & Medicine

Press release from: Coherent Market Insights

North America Is Projected To Hold a Dominant Position in

The growing prevalence of infectious diseases is fostering the growth of the peptide synthesis market. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC) in February 2020, reports that the number of visits with infectious and parasitic diseases to physician offices as the primary diagnosis was 15.5 million in 2016 in the U.S.

Moreover, key players are adopting inorganic strategies such as collaborations and this is projected to boost the market growth over the forecast period. For instance, in January 2018, Imcyse SA, a clinical-stage biotech company based in Belgium entered into a collaboration with a leading multinational pharmaceutical corporation, Pfizer, Inc. The collaboration is aimed at the development of a certain modified peptide called Imotope. This particular peptide is synthesized for treating rheumatoid arthritis and other chronic diseases.

In January 2019, SP Scientific, a manufacturer of freeze dryers/ lyophilizers and others, launched LyoS 2.0, a line-of-sight enabled lyophilizer control system. This product is able to control peptide synthesis platforms from development to production units, making cycle transfer and scale-up that much simpler.

In April 2021, In ISSAR Pharmaceuticals, involved in Peptide Technology and peptide drug innovation, has decided to license out their peptide-based New Chemical Entities (NCEs), with pre-IND filing and US patent.

In December 2019, Creative Peptides, one of the peptide experts, announced to launch of its synthetic peptide APIs for both researchers and manufacturers who are involved in the field of drug discovery and development.

Market Size – USD 315 Million in 2020 Market Growth – 6.4% Market Trends – Expanding pharmaceutical industry and R&D investment.

Coherent Market Insights celebrating 5th anniversary and offering 2000 USD off on all reports. Let’s celebrate with us.

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/4336

The top Major Competitive Players are: AAPPTec, GenScript Biotech Corporation, Bachem, Biotage, AnaSpec, Gyros Protein Technologies, CEM Corporation, Advanced ChemTech, New England Peptide and Merck KGaA among others

North America is projected to hold a dominant position in the global peptide synthesis market over the forecast period owing to growing new cases of cancer in the region. For instance, according to an article published by the American Cancer Association in 2018, reports that around 1,735,350 new cancer cases were diagnosed and 609,640 cancer deaths occurred in the U.S.

Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the global peptide synthesis market on the basis of product, technology, end use, and region:

Product Outlook (Revenue, USD Million; 2019 – 2028)
Reagents
Equipment
Peptide Synthesizers
Chromatography Equipment
Lyophilizers

Technology Outlook (Revenue, USD Million; 2019 – 2028)
Solid-phase Peptide Synthesis
Liquid-phase Peptide Synthesis
Hybrid & Recombinant Technology

End User Outlook (Revenue, USD Million; 2019 – 2028)
Pharmaceutical and Biotechnology Companies
Contract Development and Manufacturing Organizations
Academic and Research Institutes

Peptide Synthesis is the synthesis of peptide chains on demand. Peptide chains can be polymerized to form complex molecular structures like enzymes and receptors or can be linked directly to other molecules with complementary motifs, like amino acids and sugars. Peptide Synthesis is a general function that involves the nonprotein component of peptides, which may be polypeptides or non-peptides. Peptide Synthesis is the formation of various chemical and biological substances like lipids, steroids, hormones, hydrophorunsids, glycogen, vitamins, etc... Through a series of reactions catalyzed by enzymes. Peptide Synthesis involves multiple steps and requires complex enzymatic networks in order to produce high-quality products.

Read more @ https://www.coherentmarketinsights.com/market-insight/peptide-synthesis-market-4336

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Is Projected To Hold a Dominant Position in the Global Peptide Synthesis Market In The Near Future here

News-ID: 2338921 • Views:

More Releases from Coherent Market Insights

Robotic Surgery Market Outlook 2026-2033: Technological Advancements, Investment Opportunities & Global Market Dynamics | NuVasive Inc • Accuray Incorporated • Renishaw plc
Robotic Surgery Market Outlook 2026-2033: Technological Advancements, Investment …
The Robotic Surgery market is estimated to be valued at USD 12.81 Bn in 2025 and is expected to reach USD 38.22 Bn by 2032, growing at a compound annual growth rate CAGR of 16.9% from 2025 to 2032. ➤ Coherent Market Insights report provides a detailed and comprehensive analysis for "Robotic Surgery Market". Both quantitative and qualitative analyses are presented by Top Key Players, by region & country, by Type
Botox Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 | Ipsen Pharma • Galderma • Merz Pharma • Medytox Inc
Botox Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 …
The Botox market is estimated to be valued at USD 6.21 Bn in 2025 and is expected to reach USD 12.57 Bn by 2032, growing at a compound annual growth rate CAGR of 10.6% from 2025 to 2032. ➤ Latest Report on the Botox Market 2026-2033, focuses on a comprehensive analysis of the current and future prospects of the Botox industry. An in-depth analysis of historical trends, future trends, SWOT analysis,
Contraceptive Pills Market Is Going to Boom | Pfizer Inc • Bayer AG • Organon & Co
Contraceptive Pills Market Is Going to Boom | Pfizer Inc • Bayer AG • Organo …
The Contraceptive Pills market is estimated to be valued at USD 8.12 Bn in 2025 and is expected to reach USD 13.12 Bn by 2032, growing at a compound annual growth rate CAGR of 7.1% from 2025 to 2032. ➤ The Contraceptive Pills study, published by Coherent Market Insights, assessed upcoming growth prospective and provided information and useful statistics on market structure and size. For the forecast period of 2026-2033, the
Intraoral Scanners Market Outlook 2026-2033: Capacity Expansion, Investment Trends & Policy Impact Analysis | 3Shape • Align Technology • Dentsply Sirona • Carestream Dental
Intraoral Scanners Market Outlook 2026-2033: Capacity Expansion, Investment Tren …
The Intraoral Scanners market is estimated to be valued at USD 825.8 Mn in 2025 and is expected to reach USD 1,736.2 Mn by 2032, growing at a compound annual growth rate CAGR of 11.2% from 2025 to 2032. ➤ According to the latest research from Coherent Market Insights, the Intraoral Scanners Market is projected to experience significant growth between 2026 and 2033. This market intelligence report offers in-depth analysis based

All 5 Releases


More Releases for Peptide

ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support. ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established